Cripto-1 expression and its prognostic value in human bladder cancer patients

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Cripto-1 is an embryonic gene crucial for stem cell self-renewal and pluripotency.
• Overexpression of Cripto-1 is linked to tumorigenesis, recurrence, and metastasis in various cancers.
• Cripto-1 shows potential as a prognostic biomarker for several malignancies.

Purpose of the Study:

• To investigate the expression pattern of Cripto-1 in human bladder cancer.
• To determine the clinicopathological significance of Cripto-1 in bladder cancer patients.
• To evaluate Cripto-1 as a prognostic marker for bladder cancer recurrence and metastasis.

Main Methods:

• Real-time quantitative RT-PCR (qRT-PCR) for Cripto-1 expression in paired bladder tissues.
• Immunohistochemistry and immunofluorescence assays for Cripto-1 in 130 bladder cancer specimens and cell lines.
• Kaplan-Meier analysis, log-rank test, and Cox regression for survival and prognostic factor analysis.

Main Results:

• Cripto-1 expression was significantly elevated in bladder cancer tissues compared to non-cancerous tissues.
• Increased Cripto-1 expression correlated with larger tumor size and higher tumor grade.
• High Cripto-1 levels were associated with poorer recurrence/metastasis-free survival and correlated with SOX2 and Ki-67 expression.

Conclusions:

• Elevated Cripto-1 expression is implicated in bladder cancer development.
• Cripto-1 may serve as an independent prognostic factor for recurrence/metastasis-free survival in bladder cancer.
• Cripto-1 is a potential prognostic biomarker for bladder cancer patients.